Table 2 |
||||||||
|
Cell doubling rates (in days) during cell culture passages for each patient |
||||||||
|
Patient |
p1 |
p2 |
p3 |
p4 |
p5 |
p6 |
p7 |
p8 |
|
|
||||||||
|
RA-1 |
3 |
4 |
3 |
5 |
5 |
6 |
5 |
7 |
|
RA-2 |
4 |
3 |
4 |
4 |
4 |
4 |
5 |
6 |
|
RA-3 |
4 |
4 |
3 |
4 |
4 |
5 |
6 |
7 |
|
RA-4 |
4 |
4 |
4 |
3 |
4 |
6 |
6 |
6 |
|
Mean |
3.75 |
3.75 |
3.5 |
4.0 |
4.25 |
5.25 |
5.5 |
6.5 |
|
± SD |
0.43 |
0.43 |
0.50 |
0.71 |
0.43 |
0.83 |
0.50 |
0.50 |
|
|
||||||||
|
The cell doubling rate was measured by counting the cells. The day, the cell numbers were doubled after passaging of the cells is listed for each passage. p: passage; RA: rheumatoid arthritis; SD: standard deviation. |
||||||||
|
Neumann et al. Arthritis Research & Therapy 2010 12:R83 doi:10.1186/ar3010 |
||||||||
